{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"DEA\" and document_type = \"Proposed Rule\" sorted by posted_date descending", "rows": [["DEA-2026-0133-0001", "DEA", "DEA-2026-0133", "Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I", "Proposed Rule", null, "2026-01-20T05:00:00Z", 2026, 1, "2026-01-20T05:00:00Z", null, "2026-01-20T23:36:31Z", "2026-00954", 0, 0, "09000064b916130f"], ["DEA-2025-0918-0002", "DEA", "DEA-2025-0918", "Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I", "Proposed Rule", null, "2025-12-16T05:00:00Z", 2025, 12, "2025-12-16T05:00:00Z", "2026-01-16T04:59:59Z", "2025-12-23T10:00:13Z", "2025-22963", 0, 0, "09000064b90da711"], ["DEA-2025-0885-0001", "DEA", "DEA-2025-0885", "Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I", "Proposed Rule", null, "2025-12-15T05:00:00Z", 2025, 12, "2025-12-15T05:00:00Z", null, "2025-12-15T20:45:21Z", "2025-22763", 0, 0, "09000064b90d3470"], ["DEA-2025-0852-0001", "DEA", "DEA-2025-0852", "Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I", "Proposed Rule", null, "2025-12-11T05:00:00Z", 2025, 12, "2025-12-11T05:00:00Z", "2026-01-13T04:59:59Z", "2025-12-24T10:00:21Z", "2025-22495", 0, 0, "09000064b90c30e5"], ["DEA-2025-0555-0001", "DEA", "DEA-2025-0555", "Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I", "Proposed Rule", null, "2025-10-02T04:00:00Z", 2025, 10, "2025-10-02T04:00:00Z", "2025-11-04T04:59:59Z", "2025-11-04T10:00:11Z", "2025-19348", 0, 0, "09000064b8ff06ce"], ["DEA-2025-0557-0001", "DEA", "DEA-2025-0557", "Designation of P2P Methyl Glycidic Acid as a List I Chemical", "Proposed Rule", null, "2025-10-02T04:00:00Z", 2025, 10, "2025-10-02T04:00:00Z", "2025-11-04T04:59:59Z", "2025-11-04T10:00:11Z", "2025-19384", 0, 0, "09000064b8ff05d4"], ["DEA-2022-0145-0006", "DEA", "DEA-2022-0145", "Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I", "Proposed Rule", null, "2025-07-25T04:00:00Z", 2025, 7, "2025-07-25T04:00:00Z", "2025-08-26T03:59:59Z", "2025-08-21T09:01:13Z", "2025-14022", 0, 0, "09000064b8e9caad"], ["DEA-2023-0098-0002", "DEA", "DEA-2023-0098", "Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I", "Proposed Rule", null, "2025-06-26T04:00:00Z", 2025, 6, "2025-06-26T04:00:00Z", null, "2025-07-07T20:45:40Z", "2025-11462", 0, 0, "09000064b8e2ed48"], ["DEA-2025-0078-0001", "DEA", "DEA-2025-0078", "Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2025-06-10T00:00:00Z", 2025, 6, "2025-06-10T00:00:00Z", "2025-07-11T03:59:59Z", "2025-07-09T09:00:36Z", "2025-10372", 0, 0, "09000064b8ded104"], ["DEA-2025-0081-0001", "DEA", "DEA-2025-0081", "Schedules of Controlled Substances: Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I", "Proposed Rule", null, "2025-06-10T00:00:00Z", 2025, 6, "2025-06-10T00:00:00Z", "2025-07-11T03:59:59Z", "2025-07-04T09:00:31Z", "2025-10503", 0, 0, "09000064b8ded153"], ["DEA-2023-0138-0008", "DEA", "DEA-2023-0138", "Designation of Propionyl Chloride as a List I Chemical", "Proposed Rule", null, "2025-06-03T04:00:00Z", 2025, 6, "2025-06-03T04:00:00Z", "2025-07-04T03:59:59Z", "2025-07-04T09:00:30Z", "2025-09983", 0, 0, "09000064b8dd3fbb"], ["DEA-2025-0075-0001", "DEA", "DEA-2025-0075", "Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I", "Proposed Rule", null, "2025-06-03T04:00:00Z", 2025, 6, "2025-06-03T04:00:00Z", "2025-07-04T03:59:59Z", "2025-07-04T09:00:30Z", "2025-09988", 0, 0, "09000064b8dd403e"], ["DEA-2023-0029-35465", "DEA", "DEA-2023-0029", "Special Registrations for Telemedicine and Limited State Telemedicine Registrations", "Proposed Rule", null, "2025-01-17T05:00:00Z", 2025, 1, "2025-01-17T05:00:00Z", "2025-03-19T03:59:59Z", "2025-03-20T01:00:13Z", "2025-01099", 0, 0, "09000064868e2e65"], ["DEA-2024-0144-0001", "DEA", "DEA-2024-0144", "Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I", "Proposed Rule", null, "2024-12-30T05:00:00Z", 2024, 12, "2024-12-30T05:00:00Z", "2025-01-30T04:59:59Z", "2025-01-02T02:00:54Z", "2024-30359", 0, 0, "0900006486894777"], ["DEA-2024-0148-0002", "DEA", "DEA-2024-0148", "Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2024-12-30T05:00:00Z", 2024, 12, "2024-12-30T05:00:00Z", "2025-01-30T04:59:59Z", "2025-01-21T14:06:33Z", "2024-30798", 0, 0, "0900006486894772"], ["DEA-2024-0134-0001", "DEA", "DEA-2024-0134", "Possible Control of Phenethyl Bromide as a List I Chemical", "Proposed Rule", null, "2024-10-28T04:00:00Z", 2024, 10, "2024-10-28T04:00:00Z", "2024-11-28T04:59:59Z", "2024-11-27T19:58:55Z", "2024-24616", 0, 0, "09000064867e8844"], ["DEA-2024-0118-0001", "DEA", "DEA-2024-0118", "Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I", "Proposed Rule", null, "2024-09-17T04:00:00Z", 2024, 9, "2024-09-17T04:00:00Z", null, "2024-09-17T20:04:16Z", "2024-21058", 0, 0, "090000648672f856"], ["DEA-2024-0059-42928", "DEA", "DEA-2024-0059", "Schedules of Controlled Substances: Rescheduling of Marijuana", "Proposed Rule", null, "2024-08-29T04:00:00Z", 2024, 8, "2024-08-29T04:00:00Z", null, "2024-09-03T22:48:28Z", "2024-19370", 0, 0, "09000064866b30d2"], ["DEA-2023-0168-0156", "DEA", "DEA-2023-0168", "Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I; Stay", "Proposed Rule", null, "2024-06-07T04:00:00Z", 2024, 6, "2024-06-07T04:00:00Z", null, "2024-06-07T16:05:43Z", "2024-12504", 0, 0, "090000648659daf8"], ["DEA-2024-0059-0001", "DEA", "DEA-2024-0059", "Schedules of Controlled Substances: Rescheduling of Marijuana", "Proposed Rule", null, "2024-05-21T04:00:00Z", 2024, 5, "2024-05-21T04:00:00Z", "2024-07-23T03:59:59Z", "2024-12-21T02:00:50Z", "2024-11137", 0, 0, "0900006486575c28"], ["DEA-2021-0031-0007", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I", "Proposed Rule", null, "2024-04-11T04:00:00Z", 2024, 4, "2024-04-11T04:00:00Z", "2024-05-14T03:59:59Z", "2024-05-03T19:54:22Z", "2024-07694", 0, 0, "09000064864cd92b"], ["DEA-2023-0168-0155", "DEA", "DEA-2023-0168", "Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I", "Proposed Rule", null, "2024-04-09T04:00:00Z", 2024, 4, "2024-04-09T04:00:00Z", null, "2024-06-07T16:06:39Z", "2024-07473", 0, 0, "09000064864c2af7"], ["DEA-2023-0148-0026", "DEA", "DEA-2023-0148", "Controlled Substance Destruction Alternatives to Incineration - Extension of Comment Period", "Proposed Rule", null, "2024-01-03T05:00:00Z", 2024, 1, "2024-01-03T05:00:00Z", "2024-04-02T03:59:59Z", "2024-04-02T01:04:01Z", "2023-28964", 0, 0, "0900006486374cf2"], ["DEA-2023-0168-0001", "DEA", "DEA-2023-0168", "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I", "Proposed Rule", null, "2023-12-13T05:00:00Z", 2023, 12, "2023-12-13T05:00:00Z", "2024-01-13T04:59:59Z", "2024-01-13T20:44:04Z", "2023-27289", 0, 0, "09000064863304b8"], ["DEA-2023-0148-0001", "DEA", "DEA-2023-0148", "Controlled Substance Destruction Alternatives to Incineration", "Proposed Rule", null, "2023-10-31T04:00:00Z", 2023, 10, "2023-10-31T04:00:00Z", "2024-04-02T03:59:59Z", "2024-04-10T01:00:33Z", "2023-23984", 0, 0, "090000648619fc8d"], ["DEA-2023-0147-0001", "DEA", "DEA-2023-0147", "Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I", "Proposed Rule", null, "2023-10-25T04:00:00Z", 2023, 10, "2023-10-25T04:00:00Z", null, "2023-10-25T21:34:00Z", "2023-23379", 0, 0, "0900006486134ef2"], ["DEA-2023-0138-0001", "DEA", "DEA-2023-0138", "Propionyl Chloride", "Proposed Rule", null, "2023-10-12T04:00:00Z", 2023, 10, "2023-10-12T04:00:00Z", "2023-11-14T04:59:59Z", "2023-11-08T02:00:50Z", "2023-22570", 0, 0, "09000064860b9810"], ["DEA-2023-0129-0001", "DEA", "DEA-2023-0129", "Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I", "Proposed Rule", null, "2023-09-22T04:00:00Z", 2023, 9, "2023-09-22T04:00:00Z", "2023-11-22T04:59:59Z", "2023-11-22T02:03:41Z", "2023-20439", 0, 0, "0900006485fe5771"], ["DEA-2023-0059-0001", "DEA", "DEA-2023-0059", "Designation as List I Chemicals: Halides of 4-Anilinopiperidine", "Proposed Rule", null, "2023-04-14T04:00:00Z", 2023, 4, "2023-04-14T04:00:00Z", "2023-05-16T03:59:59Z", "2023-04-14T12:24:33Z", "2023-07454", 0, 0, "0900006485948d50"], ["DEA-2023-0057-0001", "DEA", "DEA-2023-0057", "Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents", "Proposed Rule", null, "2023-04-13T04:00:00Z", 2023, 4, "2023-04-13T04:00:00Z", "2023-05-16T03:59:59Z", "2023-04-20T01:01:08Z", "2023-07578", 0, 0, "0900006485940732"], ["DEA-2023-0058-0001", "DEA", "DEA-2023-0058", "Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2023-04-13T04:00:00Z", 2023, 4, "2023-04-13T04:00:00Z", "2023-05-16T03:59:59Z", "2023-05-16T01:00:59Z", "2023-07576", 0, 0, "0900006485941111"], ["DEA-2023-0049-0001", "DEA", "DEA-2023-0049", "Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I", "Proposed Rule", null, "2023-04-04T04:00:00Z", 2023, 4, "2023-04-04T04:00:00Z", null, "2023-04-04T15:48:01Z", "2023-06893", 0, 0, "09000064858d7f29"], ["DEA-2023-0029-0001", "DEA", "DEA-2023-0029", "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation", "Proposed Rule", null, "2023-03-01T05:00:00Z", 2023, 3, "2023-03-01T05:00:00Z", "2023-04-01T03:59:59Z", "2023-04-25T01:00:34Z", "2023-04248", 0, 0, "0900006485732548"], ["DEA-2023-0028-0001", "DEA", "DEA-2023-0028", "Expansion of Induction of Buprenorphine via Telemedicine Encounter", "Proposed Rule", null, "2023-03-01T05:00:00Z", 2023, 3, "2023-03-01T05:00:00Z", "2023-04-01T03:59:59Z", "2023-04-01T23:39:12Z", "2023-04217", 0, 0, "09000064857323db"], ["DEA-2023-0016-0001", "DEA", "DEA-2023-0016", "Controlled Substances Ordering System Modernization", "Proposed Rule", null, "2023-02-02T05:00:00Z", 2023, 2, "2023-02-02T05:00:00Z", "2023-04-04T03:59:59Z", "2023-04-05T01:01:13Z", "2023-01804", 0, 0, "090000648562c18e"], ["DEA-2022-0145-0001", "DEA", "DEA-2022-0145", "Schedule of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I", "Proposed Rule", null, "2022-12-23T05:00:00Z", 2022, 12, "2022-12-23T05:00:00Z", null, "2022-12-23T12:54:22Z", "2022-27278", 0, 0, "0900006485550cf4"], ["DEA-2022-0102-0001", "DEA", "DEA-2022-0102", "Designation of 4-Piperidone as a List I Chemical", "Proposed Rule", null, "2022-09-22T04:00:00Z", 2022, 9, "2022-09-22T04:00:00Z", "2022-10-25T03:59:59Z", "2022-10-20T01:01:07Z", "2022-19974", 0, 0, "090000648534f58b"], ["DEA-2022-0026-0101", "DEA", "DEA-2022-0026", "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal", "Proposed Rule", null, "2022-08-29T04:00:00Z", 2022, 8, "2022-08-29T04:00:00Z", null, "2022-08-29T12:38:14Z", "2022-18729", 0, 0, "09000064852853f2"], ["DEA-2022-0001-0591", "DEA", "DEA-2022-0001", "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing", "Proposed Rule", null, "2022-07-27T04:00:00Z", 2022, 7, "2022-07-27T04:00:00Z", null, "2022-07-27T12:21:18Z", "2022-16102", 0, 0, "09000064851ecfe2"], ["DEA-2022-0068-0001", "DEA", "DEA-2022-0068", "Schedules of Controlled Substances: Removal of Fenfluramine From Control", "Proposed Rule", null, "2022-07-19T04:00:00Z", 2022, 7, "2022-07-19T04:00:00Z", "2022-08-19T03:59:59Z", "2022-07-28T01:00:56Z", "2022-15335", 0, 0, "09000064851d1a59"], ["DEA-2022-0058-0001", "DEA", "DEA-2022-0058", "Providing Controlled Substances to Ocean Vessels, Aircraft, and Other Entities", "Proposed Rule", null, "2022-07-18T04:00:00Z", 2022, 7, "2022-07-18T04:00:00Z", "2022-09-17T03:59:59Z", "2022-09-17T01:01:02Z", "2022-15265", 0, 0, "09000064851cf62e"], ["DEA-2022-0001-0590", "DEA", "DEA-2022-0001", "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I", "Proposed Rule", null, "2022-07-06T04:00:00Z", 2022, 7, "2022-07-06T04:00:00Z", null, "2022-07-07T13:59:19Z", "2022-14372", 0, 0, "09000064851b25a1"], ["DEA-2022-0027-0001", "DEA", "DEA-2022-0027", "Schedules of Controlled Substances: Exempted Prescription Products", "Proposed Rule", null, "2022-04-12T04:00:00Z", 2022, 4, "2022-04-12T04:00:00Z", "2022-05-13T03:59:59Z", "2022-05-13T01:00:46Z", "2022-07572", 0, 0, "090000648500fc8e"], ["DEA-2022-0026-0001", "DEA", "DEA-2022-0026", "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I", "Proposed Rule", null, "2022-04-11T04:00:00Z", 2022, 4, "2022-04-11T04:00:00Z", "2022-06-11T03:59:59Z", "2022-06-12T00:21:41Z", "2022-07648", 0, 0, "090000648500addc"], ["DEA-2022-0001-0001", "DEA", "DEA-2022-0001", "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I", "Proposed Rule", null, "2022-01-14T05:00:00Z", 2022, 1, "2022-01-14T05:00:00Z", "2022-02-15T04:59:59Z", "2022-02-16T02:00:43Z", "2022-00713", 0, 0, "0900006484f1fcdd"], ["DEA-2021-0030-0001", "DEA", "DEA-2021-0030", "Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I", "Proposed Rule", null, "2021-12-07T05:00:00Z", 2021, 12, "2021-12-07T05:00:00Z", "2022-02-08T04:59:59Z", "2021-12-11T02:00:42Z", "2021-26293", 0, 0, "0900006484ea7915"], ["DEA-2021-0031-0001", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I", "Proposed Rule", null, "2021-12-07T05:00:00Z", 2021, 12, "2021-12-07T05:00:00Z", null, "2021-12-08T16:07:57Z", "2021-26263", 0, 0, "0900006484ea7b00"], ["DEA-2021-0026-0001", "DEA", "DEA-2021-0026", "Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances between Pharmacies for Initial Filling", "Proposed Rule", null, "2021-11-19T05:00:00Z", 2021, 11, "2021-11-19T05:00:00Z", "2022-01-19T04:59:59Z", "2022-01-20T02:00:23Z", "2021-24981", 0, 0, "0900006484e65ef0"], ["DEA-2021-0027-0001", "DEA", "DEA-2021-0027", "Regulation of Telepharmacy Practice", "Proposed Rule", null, "2021-11-17T05:00:00Z", 2021, 11, "2021-11-17T05:00:00Z", "2022-01-19T04:59:59Z", "2022-01-20T02:00:23Z", "2021-24948", 0, 0, "0900006484e56f76"], ["DEA-2021-0025-0001", "DEA", "DEA-2021-0025", "Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control", "Proposed Rule", null, "2021-11-04T04:00:00Z", 2021, 11, "2021-11-04T04:00:00Z", "2021-12-07T04:59:59Z", "2021-11-24T02:02:38Z", "2021-23852", 0, 0, "0900006484e17e7d"], ["DEA-2021-0013-0001", "DEA", "DEA-2021-0013", "Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I", "Proposed Rule", null, "2021-09-02T04:00:00Z", 2021, 9, "2021-09-02T04:00:00Z", "2021-10-05T03:59:59Z", "2021-10-06T01:00:36Z", "2021-18843", 0, 0, "0900006484d43832"], ["DEA-2021-0012-0001", "DEA", "DEA-2021-0012", "Schedules of Controlled Substances: Placement of Mesocarb in Schedule I", "Proposed Rule", null, "2021-08-11T04:00:00Z", 2021, 8, "2021-08-11T04:00:00Z", "2021-10-13T03:59:59Z", "2021-10-14T01:00:34Z", "2021-16489", 0, 0, "0900006484c42141"], ["DEA-2021-0011-0001", "DEA", "DEA-2021-0011", "Schedules of Controlled Substances: Placement of Amineptine in Schedule I", "Proposed Rule", null, "2021-07-22T04:00:00Z", 2021, 7, "2021-07-22T04:00:00Z", "2021-09-21T03:59:59Z", "2021-08-09T01:00:27Z", "2021-15331", 0, 0, "0900006484c078c2"], ["DEA-2019-0004-0006", "DEA", "DEA-2019-0004", "Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4\u2032-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4\u2032-Chloro-alpha-pyrrolidinovalerophenone in Schedule I", "Proposed Rule", null, "2021-07-16T04:00:00Z", 2021, 7, "2021-07-16T04:00:00Z", "2021-08-17T03:59:59Z", "2021-08-18T13:24:48Z", "2021-15114", 0, 0, "0900006484bfbc10"], ["DEA-2021-0009-0001", "DEA", "DEA-2021-0009", "Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine", "Proposed Rule", null, "2021-03-30T04:00:00Z", 2021, 3, "2021-03-30T04:00:00Z", "2021-06-02T03:59:59Z", "2021-05-11T16:48:13Z", "2021-05346", 0, 0, "0900006484a875c3"], ["DEA-2019-0002-0005", "DEA", "DEA-2019-0002", "Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I", "Proposed Rule", null, "2021-03-30T04:00:00Z", 2021, 3, "2021-03-30T04:00:00Z", "2021-04-30T03:59:59Z", "2021-04-01T13:19:22Z", "2021-06553", 0, 0, "0900006484a8761d"], ["DEA-2021-0007-0001", "DEA", "DEA-2021-0007", "Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2021-03-18T04:00:00Z", 2021, 3, "2021-03-18T04:00:00Z", "2021-04-20T03:59:59Z", "2021-04-20T01:00:28Z", "2021-05589", 0, 0, "0900006484a6ff9d"], ["DEA-2021-0006-0001", "DEA", "DEA-2021-0006", "Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2021-03-03T05:00:00Z", 2021, 3, "2021-03-03T05:00:00Z", "2021-04-03T03:59:59Z", "2021-04-02T01:00:56Z", "2021-04214", 0, 0, "0900006484a5c7c4"], ["DEA-2021-0003-0032", "DEA", "DEA-2021-0003", "Suspicious Orders of Controlled Substances", "Proposed Rule", null, "2021-02-25T05:00:00Z", 2021, 2, "2021-02-25T05:00:00Z", "2021-03-30T03:59:59Z", "2021-03-30T01:00:21Z", "2021-03361", 0, 0, "0900006484a4d934"], ["DEA-2021-0005-0001", "DEA", "DEA-2021-0005", "Amending Regulations To Require Online Submission of Applications for and Renewals of Registration", "Proposed Rule", null, "2021-01-07T05:00:00Z", 2021, 1, "2021-01-07T05:00:00Z", "2021-03-09T04:59:59Z", "2021-03-09T02:00:26Z", "2020-28532", 0, 0, "09000064849e5644"], ["DEA-2021-0001-0001", "DEA", "DEA-2021-0001", "Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals", "Proposed Rule", null, "2020-12-21T05:00:00Z", 2020, 12, "2020-12-21T05:00:00Z", "2021-02-20T04:59:59Z", "2021-02-25T13:50:56Z", "2020-26813", 0, 0, "09000064849aefe0"], ["DEA-2021-0004-0001", "DEA", "DEA-2021-0004", "Schedules of Controlled Substances: Removal of Samidorphan From Control", "Proposed Rule", null, "2020-12-10T05:00:00Z", 2020, 12, "2020-12-10T05:00:00Z", "2021-01-12T04:59:59Z", "2021-01-12T02:00:35Z", "2020-26812", 0, 0, "090000648499556e"], ["DEA-2020-0035-0001", "DEA", "DEA-2020-0035", "Partial Filling of Prescriptions for Schedule II Controlled Substances", "Proposed Rule", null, "2020-12-04T05:00:00Z", 2020, 12, "2020-12-04T05:00:00Z", "2021-02-03T04:59:59Z", "2021-02-03T02:00:28Z", "2020-26291", 0, 0, "0900006484985b6b"], ["DEA-2020-0038-0001", "DEA", "DEA-2020-0038", "Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I", "Proposed Rule", null, "2020-12-03T05:00:00Z", 2020, 12, "2020-12-03T05:00:00Z", null, "2020-12-23T16:19:53Z", "2020-26301", 0, 0, "090000648498412a"], ["DEA-2021-0003-0001", "DEA", "DEA-2021-0003", "Suspicious Orders of Controlled Substances", "Proposed Rule", null, "2020-11-02T05:00:00Z", 2020, 11, "2020-11-02T05:00:00Z", "2021-01-05T04:59:59Z", "2021-02-25T16:35:27Z", "2020-21302", 0, 0, "0900006484945a99"], ["DEA-2020-0029-0001", "DEA", "DEA-2020-0029", "Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017", "Proposed Rule", null, "2020-10-05T04:00:00Z", 2020, 10, "2020-10-05T04:00:00Z", "2020-12-05T04:59:59Z", "2020-12-06T02:00:55Z", "2020-21675", 0, 0, "09000064848ce421"], ["DEA-2020-0027-0001", "DEA", "DEA-2020-0027", "Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration", "Proposed Rule", null, "2020-09-30T04:00:00Z", 2020, 9, "2020-09-30T04:00:00Z", "2020-12-01T04:59:59Z", "2020-12-01T02:02:00Z", "2020-19309", 0, 0, "09000064848a25f0"], ["DEA-2020-0025-0001", "DEA", "DEA-2020-0025", "Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I", "Proposed Rule", null, "2020-08-27T04:00:00Z", 2020, 8, "2020-08-27T04:00:00Z", "2020-09-29T03:59:59Z", "2020-09-28T01:01:08Z", "2020-19007", 0, 0, "0900006484823d52"], ["DEA-2020-0022-0001", "DEA", "DEA-2020-0022", "Reporting of Theft or Significant Loss of Controlled Substances", "Proposed Rule", null, "2020-07-29T04:00:00Z", 2020, 7, "2020-07-29T04:00:00Z", "2020-09-29T03:59:59Z", "2020-09-28T01:01:01Z", "2020-15635", 0, 0, "09000064847b3625"], ["DEA-2020-0020-0001", "DEA", "DEA-2020-0020", "Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I", "Proposed Rule", null, "2020-07-13T04:00:00Z", 2020, 7, "2020-07-13T04:00:00Z", "2020-08-13T03:59:59Z", "2020-08-13T01:01:57Z", "2020-14901", 0, 0, "0900006484745b40"], ["DEA-2020-0017-0001", "DEA", "DEA-2020-0017", "Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I", "Proposed Rule", null, "2020-06-18T04:00:00Z", 2020, 6, "2020-06-18T04:00:00Z", null, "2020-06-19T13:24:57Z", "2020-12304", 0, 0, "09000064846f8a81"], ["DEA-2020-0016-0001", "DEA", "DEA-2020-0016", "Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I", "Proposed Rule", null, "2020-05-15T04:00:00Z", 2020, 5, "2020-05-15T04:00:00Z", "2020-06-16T03:59:59Z", "2020-05-26T16:52:37Z", "2020-09599", 0, 0, "090000648460372c"], ["DEA-2020-0015-0001", "DEA", "DEA-2020-0015", "Schedules of Controlled Substances: Placement of Zipeprol in Schedule I", "Proposed Rule", null, "2020-05-14T04:00:00Z", 2020, 5, "2020-05-14T04:00:00Z", "2020-07-14T03:59:59Z", "2020-07-14T01:01:18Z", "2020-09592", 0, 0, "09000064845f501a"], ["DEA-2020-0009-0001", "DEA", "DEA-2020-0009", "Schedules of Controlled Substances: Placement of 4,4\u2032-DMAR in Schedule I", "Proposed Rule", null, "2020-04-07T04:00:00Z", 2020, 4, "2020-04-07T04:00:00Z", "2020-06-09T03:59:59Z", "2020-10-19T14:31:29Z", "2020-07095", 0, 0, "090000648448e827"], ["DEA-2020-0008-0001", "DEA", "DEA-2020-0008", "Controls To Enhance the Cultivation of Marihuana for Research in the United States", "Proposed Rule", null, "2020-03-23T04:00:00Z", 2020, 3, "2020-03-23T04:00:00Z", "2020-05-23T03:59:59Z", "2020-06-05T01:02:20Z", "2020-05796", 0, 0, "090000648445f2a9"], ["DEA-2020-0007-0001", "DEA", "DEA-2020-0007", "Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants", "Proposed Rule", null, "2020-03-16T04:00:00Z", 2020, 3, "2020-03-16T04:00:00Z", "2020-05-16T03:59:59Z", "2020-05-16T01:01:44Z", "2020-05159", 0, 0, "0900006484447dc2"], ["DEA-2020-0005-0001", "DEA", "DEA-2020-0005", "Registration Requirements for Narcotic Treatment Programs with Mobile Components", "Proposed Rule", null, "2020-02-26T05:00:00Z", 2020, 2, "2020-02-26T05:00:00Z", "2020-04-28T03:59:59Z", "2020-04-29T01:00:40Z", "2020-03627", 0, 0, "09000064843b4e82"], ["DEA-2020-0002-0001", "DEA", "DEA-2020-0002", "Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I", "Proposed Rule", null, "2020-01-30T05:00:00Z", 2020, 1, "2020-01-30T05:00:00Z", "2020-03-03T04:59:59Z", "2020-03-03T02:02:48Z", "2020-01681", 0, 0, "090000648430aa75"], ["DEA-2017-0010-0005", "DEA", "DEA-2017-0010", "Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I", "Proposed Rule", null, "2019-10-30T04:00:00Z", 2019, 10, "2019-10-30T04:00:00Z", "2019-11-30T04:59:59Z", "2019-11-28T02:03:10Z", "2019-23626", 0, 0, "0900006484109366"], ["DEA-2019-0013-0001", "DEA", "DEA-2019-0013", "Management of Quotas for Controlled Substances and List I Chemicals", "Proposed Rule", null, "2019-10-23T04:00:00Z", 2019, 10, "2019-10-23T04:00:00Z", "2019-12-24T04:59:59Z", "2019-12-25T02:02:14Z", "2019-21989", 0, 0, "09000064840ec847"], ["DEA-2019-0012-0001", "DEA", "DEA-2019-0012", "Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II", "Proposed Rule", null, "2019-09-17T04:00:00Z", 2019, 9, "2019-09-17T04:00:00Z", "2019-11-19T04:59:59Z", "2019-11-20T02:02:04Z", "2019-19786", 0, 0, "0900006483f86082"], ["DEA-2019-0011-0001", "DEA", "DEA-2019-0011", "Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals", "Proposed Rule", null, "2019-09-13T04:00:00Z", 2019, 9, "2019-09-13T04:00:00Z", "2019-11-13T04:59:59Z", "2019-11-13T02:04:07Z", "2019-19787", 0, 0, "0900006483f545ad"], ["DEA-2019-0007-0001", "DEA", "DEA-2019-0007", "Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control", "Proposed Rule", null, "2019-08-21T04:00:00Z", 2019, 8, "2019-08-21T04:00:00Z", "2019-09-21T03:59:59Z", "2021-03-14T09:28:20Z", "2019-17630", 0, 0, "0900006483e7ef77"], ["DEA-2019-0004-0001", "DEA", "DEA-2019-0004", "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I", "Proposed Rule", null, "2019-05-01T04:00:00Z", 2019, 5, null, null, "2019-05-16T15:23:10Z", "2019-08704", 0, 0, "0900006483c223a6"], ["DEA-2016-0020-0008", "DEA", "DEA-2016-0020", "Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I", "Proposed Rule", null, "2019-04-08T04:00:00Z", 2019, 4, "2019-04-08T04:00:00Z", "2019-05-09T03:59:59Z", "2019-05-09T01:01:30Z", "2019-06853", 0, 0, "0900006483b716a9"], ["DEA-2019-0001-0001", "DEA", "DEA-2019-0001", "New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances", "Proposed Rule", null, "2019-02-21T05:00:00Z", 2019, 2, "2019-02-21T05:00:00Z", "2019-04-23T03:59:59Z", "2019-04-23T01:01:00Z", "2019-02875", 0, 0, "0900006483a94210"], ["DEA-2019-0002-0001", "DEA", "DEA-2019-0002", "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I", "Proposed Rule", null, "2018-12-28T05:00:00Z", 2018, 12, "2018-12-28T05:00:00Z", null, "2019-04-08T13:18:54Z", "2018-28110", 0, 0, "09000064839cbf72"], ["DEA-2018-0011-0001", "DEA", "DEA-2018-0011", "Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I", "Proposed Rule", null, "2018-06-13T04:00:00Z", 2018, 6, null, null, "2018-09-28T13:47:25Z", "2018-12669", 0, 0, "09000064834046ca"], ["DEA-2018-0010-0001", "DEA", "DEA-2018-0010", "Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA into Schedule I", "Proposed Rule", null, "2018-05-30T04:00:00Z", 2018, 5, null, null, "2018-05-30T12:36:32Z", "2018-11531", 0, 0, "090000648330d3ac"], ["DEA-2018-0009-0001", "DEA", "DEA-2018-0009", "Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I", "Proposed Rule", null, "2018-05-10T04:00:00Z", 2018, 5, "2018-05-10T04:00:00Z", "2018-06-12T03:59:59Z", "2018-06-13T01:05:58Z", "2018-10008", 0, 0, "09000064832540d8"], ["DEA-2018-0005-0001", "DEA", "DEA-2018-0005", "Controlled Substances Quotas", "Proposed Rule", null, "2018-04-19T04:00:00Z", 2018, 4, "2018-04-19T04:00:00Z", "2018-05-05T03:59:59Z", "2018-05-08T01:01:01Z", "2018-08111", 0, 0, "09000064831895a3"], ["DEA-2016-0003-0003", "DEA", "DEA-2016-0003", "Schedules of Controlled Substances: Placement of MAB-CHMINACA into Schedule I", "Proposed Rule", null, "2018-01-30T05:00:00Z", 2018, 1, "2018-01-30T05:00:00Z", "2018-03-02T04:59:59Z", "2018-03-02T02:02:45Z", "2018-01747", 0, 0, "0900006482e7c993"], ["DEA-2018-0001-0001", "DEA", "DEA-2018-0001", "Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I", "Proposed Rule", null, "2017-12-29T05:00:00Z", 2017, 12, "2017-12-29T05:00:00Z", null, "2018-01-05T13:28:52Z", "2017-28114", 0, 0, "0900006482d831c7"], ["DEA-2017-0016-0001", "DEA", "DEA-2017-0016", "Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-related Substances in Schedule I", "Proposed Rule", null, "2017-12-13T05:00:00Z", 2017, 12, null, null, "2017-12-19T14:27:41Z", "2017-26854", 0, 0, "0900006482d01f40"], ["DEA-2017-0013-0001", "DEA", "DEA-2017-0013", "Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl into Schedule I", "Proposed Rule", null, "2017-11-21T05:00:00Z", 2017, 11, null, null, "2017-11-22T14:39:02Z", "2017-25077", 0, 0, "0900006482c98388"], ["DEA-2017-0011-0001", "DEA", "DEA-2017-0011", "Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I", "Proposed Rule", null, "2017-09-12T04:00:00Z", 2017, 9, null, null, "2017-09-12T14:11:38Z", "2017-19283", 0, 0, "0900006482b28c4e"], ["DEA-2017-0010-0001", "DEA", "DEA-2017-0010", "Schedules of Controlled Substances: Temporary Placement of FUB-AMB into Schedule I", "Proposed Rule", null, "2017-09-11T04:00:00Z", 2017, 9, null, null, "2017-09-11T18:59:42Z", "2017-17639", 0, 0, "0900006482b23e2a"], ["DEA-2017-0008-0001", "DEA", "DEA-2017-0008", "Schedules of Controlled Substances: Removal of Naldemedine from Control", "Proposed Rule", null, "2017-07-12T04:00:00Z", 2017, 7, "2017-07-12T04:00:00Z", "2017-08-12T03:59:59Z", "2017-08-11T01:02:14Z", "2017-14482", 0, 0, "0900006482910c2c"], ["DEA-2017-0005-0001", "DEA", "DEA-2017-0005", "Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I", "Proposed Rule", null, "2017-06-02T04:00:00Z", 2017, 6, null, null, "2017-06-02T13:11:59Z", "2017-11215", 0, 0, "090000648267f8ac"], ["DEA-2017-0004-0001", "DEA", "DEA-2017-0004", "Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I", "Proposed Rule", null, "2017-03-23T04:00:00Z", 2017, 3, null, null, "2017-03-23T13:53:51Z", "2017-05728", 0, 0, "090000648251fac5"]], "truncated": false, "filtered_table_rows_count": 175, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by posted_date desc limit 101", "params": {"p0": "DEA", "p1": "Proposed Rule"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule", "results": [{"value": "DEA", "label": "DEA", "count": 175, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Proposed+Rule", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule", "results": [{"value": "Proposed Rule", "label": "Proposed Rule", "count": 175, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule", "results": [{"value": 2020, "label": 2020, "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2020", "selected": false}, {"value": 2021, "label": 2021, "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2021", "selected": false}, {"value": 2016, "label": 2016, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2016", "selected": false}, {"value": 2023, "label": 2023, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2023", "selected": false}, {"value": 2025, "label": 2025, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2025", "selected": false}, {"value": 2017, "label": 2017, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2017", "selected": false}, {"value": 2022, "label": 2022, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2022", "selected": false}, {"value": 2024, "label": 2024, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2024", "selected": false}, {"value": 2008, "label": 2008, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2009", "selected": false}, {"value": 2010, "label": 2010, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2010", "selected": false}, {"value": 2019, "label": 2019, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2019", "selected": false}, {"value": 2007, "label": 2007, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2007", "selected": false}, {"value": 2014, "label": 2014, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2014", "selected": false}, {"value": 2015, "label": 2015, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2015", "selected": false}, {"value": 2018, "label": 2018, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2018", "selected": false}, {"value": 2011, "label": 2011, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2011", "selected": false}, {"value": 2013, "label": 2013, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2013", "selected": false}, {"value": 2012, "label": 2012, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2012", "selected": false}, {"value": 2026, "label": 2026, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&posted_year=2026", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet=posted_month"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_facet_date=last_modified"}], "next": "2017-03-23T04~3A00~3A00Z,DEA-2017-0004-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Proposed+Rule&_next=2017-03-23T04~3A00~3A00Z%2CDEA-2017-0004-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 2481.222579954192, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}